We have characterised the protein interaction of TGFBR2 associated with potential colorectal and lung cancer comorbidity, explaining how the mutation of Ile 73 to Val (residue 50 in the PDB structure) can cause the loss of the interaction and this, in turn, distorts the function. Here, TGFBR2 is linked to lung carcinoma.